XRAY DENTSPLY SIRONA Inc.
Dental Equipment & Supplies · Nasdaq · SEC CIK 818479 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.4%
TTM net income YoY86.3%
TTM EPS YoY86.1%
Revenue 3-yr CAGR-3.2%
Net income 3-yr CAGR—
Margins
Gross margin50.5%
Operating margin-1.5%
Net margin-3.4%
FCF margin2.9%
EBITDA margin7.9%
Returns
ROE-8.5%
ROA-2.2%
ROIC (approx.)-1.3%
Asset turnover0.66x
Leverage & solvency
Liabilities / assets73.9%
Debt / equity1.62x
Current ratio1.63x
Interest coverage-0.59x
Cash quality & payout
Operating cash flow / net income-2.25x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue4.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.68B | $3.79B | $3.96B | $3.92B | $4.23B |
| Cost of revenue | $1.84B | $1.83B | $1.88B | $1.79B | $1.88B |
| Gross profit | $1.84B | $1.96B | $2.09B | $2.13B | $2.35B |
| R&D expense | $150.00M | $165.00M | $184.00M | $174.00M | $171.00M |
| SG&A expense | $1.44B | $1.60B | $1.61B | $1.59B | $1.55B |
| Operating income | -$422.00M | -$879.00M | -$85.00M | -$937.00M | $608.00M |
| Interest expense | $88.00M | $69.00M | $81.00M | $65.00M | $61.00M |
| Pretax income | -$486.00M | -$936.00M | -$175.00M | -$1.05B | $545.00M |
| Income tax | $112.00M | -$26.00M | -$43.00M | -$105.00M | $134.00M |
| Net income | -$598.00M | -$910.00M | -$132.00M | -$950.00M | $411.00M |
| EBITDA | -$70.00M | -$530.00M | $258.00M | -$609.00M | $955.00M |
| EPS (basic) | -3.00 | -4.48 | -0.62 | -4.41 | 1.88 |
| EPS (diluted) | -3.00 | -4.48 | -0.62 | -4.41 | 1.87 |
| Dividends declared per share | 0.64 | 0.64 | 0.56 | 0.50 | 0.43 |
| Weighted avg. shares (diluted) | 199.40M | 203.20M | 212.00M | 215.50M | 220.20M |
| Balance sheet | |||||
| Cash & equivalents | $326.00M | $272.00M | $334.00M | $365.00M | $339.00M |
| Inventory | $642.00M | $564.00M | $624.00M | $627.00M | $515.00M |
| Current assets | $2.02B | $1.75B | $1.97B | $1.89B | $1.85B |
| PP&E, net | $861.00M | $766.00M | $800.00M | $761.00M | $773.00M |
| Goodwill | $1.15B | $1.60B | $2.44B | $2.69B | $3.98B |
| Intangibles | $974.00M | $1.21B | $1.71B | $1.90B | $2.32B |
| Total assets | $5.43B | $5.75B | $7.37B | $7.64B | $9.24B |
| Current liabilities | $1.34B | $1.59B | $1.43B | $1.17B | $1.26B |
| Short-term debt | $313.00M | $549.00M | $322.00M | $118.00M | $182.00M |
| Long-term debt | $2.02B | $1.59B | $1.80B | $1.83B | $1.91B |
| Total debt | $2.33B | $2.13B | $2.12B | $1.94B | $2.10B |
| Total liabilities | $4.09B | $3.81B | $4.08B | $3.83B | $4.24B |
| Shareholders' equity | $1.34B | $1.94B | $3.29B | $3.81B | $5.00B |
| Net debt | $2.00B | $1.86B | $1.78B | $1.58B | $1.76B |
| Shares outstanding | 199.60M | 198.80M | 207.20M | 215.20M | 217.40M |
| Cash flow statement | |||||
| Operating cash flow | $235.00M | $461.00M | $377.00M | $517.00M | $657.00M |
| Capital expenditure | $131.00M | $180.00M | $149.00M | $149.00M | $142.00M |
| Free cash flow | $104.00M | $281.00M | $228.00M | $368.00M | $515.00M |
| Investing cash flow | -$132.00M | -$197.00M | -$89.00M | -$138.00M | -$358.00M |
| Financing cash flow | -$80.00M | -$302.00M | -$307.00M | -$329.00M | -$379.00M |
| Depreciation & amortization | $352.00M | $349.00M | $343.00M | $328.00M | $347.00M |
| Stock-based compensation | $33.00M | $39.00M | $46.00M | $59.00M | $48.00M |
| Dividends paid | $128.00M | $126.00M | $116.00M | $104.00M | $92.00M |
| Share buybacks | $0 | $250.00M | $300.00M | $150.00M | $200.00M |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.